Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Delivering IGF-1 with PLGA microspheres improves stem cell regeneration for tissues.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Rituximab may cause skin issues, but baricitinib can help improve them.

Injectable therapy, especially with dutasteride, may help with hair loss, but more research is needed.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

The new nanoparticles could improve melanoma treatment by working better than current options.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

The new treatment was safe and may effectively treat male pattern hair loss.

Ultrasound helps in safe fat transfer for buttock augmentation, but it's costly and time-consuming; the fat transfer technique is effective with high patient satisfaction.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.